Infographic: Pros and cons of preclinical models of non-alcoholic steatohepatitis

BioTechniques News
Annie Coulson

Non-alcoholic steatohepatitis (NASH) is a condition in which fat accumulates in the liver in people who drink little or no alcohol. Despite widespread R&D effort, no regulatory approved therapeutic drugs are available, because traditional preclinical models fail to predict the efficacy of potential drugs in humans.

In this infographic, we compare four preclinical NASH models: in vitro 2D models, in vitro 3D spheroid models, in vivo animal models and in vitro organ-on-a-chip models, highlighting the pros and cons of each.

[ui-tabs]
[ui-tab title=”Register”]

[/ui-tab]
[ui-tab title=”More information”]

Discover:

An introduction to non-alcoholic liver disease
The pros and cons of various disease models
NASH-in-a-box

[/ui-tab]
[/ui-tabs]

Illustration by Hannah Morton.

The post Infographic: Pros and cons of preclinical models of non-alcoholic steatohepatitis appeared first on BioTechniques.

Full BioTechniques Article here